Refine your search
Collections
Co-Authors
Journals
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z All
Dugad, Sushma
- Paradoxical Reaction in a case of Brain Tuberculoma
Abstract Views :236 |
Authors
Affiliations
1 Department of TB Chest, Dr. Vasantrao Pawar Medical College Hospital and Research Centre, Nashik, IN
1 Department of TB Chest, Dr. Vasantrao Pawar Medical College Hospital and Research Centre, Nashik, IN
Source
MVP Journal of Medical Sciences, Vol 1, No 2 (2014), Pagination: 101–103Abstract
A 15 year old male was diagnosed to have central nervous system (cns) tuberculosis with ataxia. After starting him on conventional anti tuberculous treatment he deteriorated both clinically and radiologically. On investigation the diagnosis of drug resistant tuberculosis was ruled out and corticosteroid treatment was added. Eventually patient improved symptomatically and had good weight gain.Keywords
Brain, Paradoxical reaction, TuberculomaFull Text
- Study of Diagnostic Importance of Adenosine Deaminase (ADA) Level in Pleural Effusions
Abstract Views :215 |
PDF Views:78
Authors
Source
MVP Journal of Medical Sciences, Vol 2, No 2 (2015), Pagination: 104-109Abstract
Introduction: Pleural effusion is the abnormal accumulation of fluid in the pleural space. TB is the most common cause of pleural effusion worldwide (30-60%). The pleural fluid activity of adenosine deaminase (ADA) is one of the best, providing reliable basis for a treatment decision, particularly in excluding the diagnosis of tuberculosis, due to its high sensitivity. Aims and Objectives: To assess the importance of adenosine deaminase(ADA) level in the diagnosis of pleural effusion. To assess Adenosine Deaminase Activity (ADA) in tuberculosis pleural effusion and assess the sensitivity and specificity of ADA levels. Materials and Methods: This study was performed at the Department of Pulmonary Medicine at tertiary care centre. The study comprised of 75 patients of pleural effusion having Age > 14 years, Clinical and Radiological evidence of Pleural Effusions&Patients willing for ADA examination. Patients having Age > 65 years, minimal nontappable effusion, not giving consent for ADA examination patient were excluded from the study. Detailed history, thorough physical examination, radiological findings, haematological and biochemical findings were recorded in the proforma. Pleural aspiration was performed on all patients. Macroscopic findings, cytological, microbiological and biochemical analysis of pleural fluid were performed in all patients including ADA level. PCR for Mycobacterium tuberculosis was also assessed in pleural fluid. Pleural fluid Adenosine deaminase level was measured by Giusti and Galanti method. Result: In our study out of 45 patients with tuberculosis pleural effusion ADA was more than 40IU/L in 42 (93.33%) and less than40IU/L in 3 (6.66 %). Our study showed a mean ADA of 107.7 IU/L Using a cut off of greater 40IU/L we got a sensitivity and specificity of 93.3% and 90% respectively and Positive predictive value 93.3% and Negative predictive value 90%. Conclusion: Pleural fluid ADA activity has been shown to be a valuable biochemical marker that has a high sensitivity and specificity for TB diagnosis.Keywords
ADA, Pleural Effusion, Tuberculosis.References
- Oliveira HG, Rossatto ER, Prolla JC. Pleural fluid adenosine deaminase and lymphocyte proportion: clinical usefulness in the diagnosis of tuberculosis. Cytopathology. 1994; 5(1):27-32.
- Martin L. Mayse. Disorder of Pleura Space. Alfred P. Fishman, Jack A.Elias, Jay A. Fishman, Michael A.Grippi, Robert M.Senior,Allan I. Pack Fishmans pulmonary diseases and disorders. 4th ed. 9:1487-9.
- Disease a Month. pleural tuberculosis. 2007 Jan; 53(1).
- Richard W. Light disorders of pleura and mediastinum. Harrisons principles of internal medicine. 17th ed. Vol 2. p. 1658-60.
- Richard W. Update on tuberculous pleural effusion. Light. 2010 Mar 21. Angeline A. Lazarus, Sean McKay, Russell Gilbert.
- Burgess LJ, Maritz FJ, Le Roux I, Taljaard JJ. Use of Adenosine Deaminase as a diagnostic tool for tuberculous pleurisy. Thorax. 1995; 50:672-4.
- Valdes L, Alvarez D, Jose ES, Juanatey JRG, Pose A, Valle JM, Salgueiro M, Suarez JRR. Thorax. 1995; 50:600-3.
- Sharma SK, Suresh V, Mohan A, et al. A prospective study of sensitivity and specificity of adenosine deaminase in a diagnosis of tubercular pleural effusion. Indian J Chest Dis Allied Sci. 2001; 43:149-55.
- Ibrahim WH, Ghadban W, Khinji A, et al. Does pleural tuberculosis disease pattern differ among developed and developing countries. Respir Med. 2005; 99:1038-45.
- Neves DD, Dias RM, Ledo AJ. Dacunha; Federal University the brazilian Journal of Infectious Diseases 2007; 11(1):83- 8.
- Moudgil H, Sridhar, Leith AG. Reactivation disease: the commonest form of tuberculous effusion in Edinburgh, 1990-1991. Respir Med. 1994; 88:301-4.
- Morehead RS. Tuberculosis of the pleura. Southern Medical Journal. 1998; 91:630-4.
- Maher GG, Berger JW, et al. Massive pleural effusion and non malignant causes in 46 patients. Am Rev Resp Dis. 1972; 105:458-60.
- Light R. W Clinical menifestations and useful tests. pleural diseases. 4th Ed. Lippincott Willams and Wilkins; 2001.
- Prasad R, Mukerji T, et al. Adenosine deaminase activity in pleural fluid. Indian J Chest Allied Sci. 1992; 34:123-6.
- Gilhotra R, Seghal S, Gindal SK, et al. Pleural biopsy and adenosine deaminase activity in effusions of different etiologies. Lung India. 1989; 3:122-4.
- Bacteriological Profile in Sputum and their Antibiogram among the Patients of Acute Exacerbation of COPD
Abstract Views :250 |
PDF Views:82
Authors
Affiliations
1 Department of Respiratory Medicine, Dr. Vasantrao Pawar Medical College Hospital & Research Centre, Nashik - 422003, Maharashtra, IN
1 Department of Respiratory Medicine, Dr. Vasantrao Pawar Medical College Hospital & Research Centre, Nashik - 422003, Maharashtra, IN
Source
MVP Journal of Medical Sciences, Vol 4, No 2 (2017), Pagination: 113-117Abstract
Background and Objectives: Chronic Obstructive Pulmonary Disease (COPD) is an important cause of disability and death globally and scenario has been infact worsened. Acute exacerbation of COPD (AECOPD) is associated with airway inflammation resulting in increased air trapping, further obstruction of airways and deterioration of gas diffusion. Objectives: The objective of this study is to find out the bacteriological profile and their antibiogram in AECOPD and to study the clinical presentation of AECOPD patients. Materials and Methods: This is a cross sectional study comprising of 45 patients diagnosed with AECOPD. Before starting on antibiotics all patients sputum was sent for culture and sensitivity. All patients were instructed to collect early morning, deep coughed sputum into a sterile sputum container (preferably two). Results: The present study reveals that total 45 cases, 89% were males and 11% were females. The most common organisms isolated were gram negative bacilli (71%) and gram positive bacilli (29%). Pseudomonas aueroginosa was the commonest bacteria isolated (26.7%) followed by streptococcus pneumonia (22.2%), Klebsiella pneumoniae (20%). The drug sensitivity testing revealed that Ciprofloxacin with amikacin is the best empirical antibiotic followed by Cephalosporin with amikacin. Conclusion: AECOPD is more common in adult males above the age of fifty five years secondary to smoking practices. As an empirical therapy in AECOPD patients the best choice of antibiotic therapy would be Ciprofloxacin with amikacin. Other best monotherapy antibiotic would be piperacillin with tazobactam or cefoperazone with sulbactumKeywords
AECOPD-Acute Exacerbation of Copd.References
- Gold intiative for chronic obstructive lung disease. Available from: www.goldcopd.org
- Wedzicha AA, Hurst JR, Calverley PMA, Albert RK, Anzueto A. Management of COPD exacerbations: A European respiratory society/American thoracic society guideline. Eur Respir J. 2017; 49:1600791. https://doi.org/10.1183/13993003.00791-2016 PMid:28298398
- Rodriguez- Roisin R. Toward consensus definition for COPD exacerbations. Chest. 2000; 117:398–401. https:// doi.org/10.1378/chest.117.5_suppl_2.398S
- Macintyre N, Huang YC. Acute exacerbation and respiratory failure in COPD. Proc am thoracsoc. 2008; 5:530–5. https:// doi.org/10.1513/pats.200707-088ET PMid:18453367 PMCid: PMC2645331
- Arora N., Daga MK, et al. Microbial pattern of acute infective exacerbation of chronic obstructive airway disease in a hospital based study. Indian Chest Dis Allied Sci. 2001; 43:157–62.
- Seneff et al. Hospital and 1 year survival of patients admitted to ICU with AECOPD. JAMA. 1995; 274:1852–7. https:// doi.org/10.1001/jama.274.23.1852 https://doi.org/10.1001/ jama.1995.03530230038027 PMid:7500534
- Sanjay S. Infectious etiology of acute exacerbations of chronic bronchitis. Chest. 2000; 117(May 5):375S–85S.
- Nestor S, Torres A, et al. Bronchial microbial patterns in severe exacerbations of Chronic Obstructive Pulmonary Disease (COPD) requiring mechanical ventilation. AMJ Resp Crit Care Med. 1998; 157:1498–505. https://doi.org/10.1164/ajrccm.157.5.9711044 PMid:9603129
- Sanjay S, Murphy TF. Bacterial infection in chronic obstructive pulmonary disease in 2000: A State-of-the-Art Review. Clinical Microbiology Reviews. 2001; 14(2):336–63. https:// doi.org/10.1128/CMR.14.2.336-363.2001 PMid:11292642 PMCid:PMC88978
- Beasleyet V. Lung microbiology and exacerbations in COPD. Int J Chron Obstruct Pulmon Dis. 2012; 7:555– 69. DOI: 10.2147/COPD.S28286 https://doi.org/10.2147/ COPD.S28286
- Michael SN. Antibiotic therapy of exacerbations of chronic bronchitis. Seminars in Resp Inf. 2000; 15(1):59–70. https:// doi.org/10.1053/srin.2000.0150059
- Miravitlles M, Mayordomo C, Arte´s M, Sanchez-Agudo L, Nicolau F, Segu JL and on Behalf of the EOLO Group. Treatment of chronic obstructive pulmonary disease and its exacerbations in general practice. Respir Med 1999; 93: 173–9. https://doi.org/10.1016/S0954-6111(99)90004-5
- Adams SG, Melo J, Luther M, Anzueto A. Antibiotics are associated with lower relapse rates in outpatients with acute exacerbations of COPD. Chest. 2000; 117:1345–52. https:// doi.org/10.1378/chest.117.5.1345 PMid:10807821
- Vogel F. A guide to the treatment of lower respiratorytract infections. Drugs. 1995; 50(1):62–72. https://doi.org/10.2165/00003495-199550010-00006 PMid:7588090
- Chawla K, et al. Bacteriological profile and their antibiogram from cases of acute exacerbations of chronicobstructive pulmonary disease: A hospital based study. JCDR.2008; 2(1):612–6.
- Manino DM, Homa DM, Akinbami LJ, Ford ES, Redd SC.Chronic obstructive pulmonary disease surveillance: United States, 1971-2000. MMWR Surveill Summ. 2002; 51:1–16.
- Chen JC, Manino DM. Worldwide epidemiology of chronic obstructive pulmonary disease. Curr Opin Pulm Med. 1999; 5:93–9. https://doi.org/10.1097/00063198-19990300000003
- Anthonisen NR, Manfreda J, Warren CP, et al. Antibiotic therapy in exacerbations of chronic obstructive pulmonary disease. Ann Intern Med. 1987; 106:196–204. https://doi.org/10.7326/0003-4819-106-2-196 PMid:3492164
- Bochen K, Krasowska A, Milaniuk S, Kulczyńska M, Prystupa A, Dzida G. Erythrocyte sedimentation rate- an old marker with new applications. JPCCR. 2011; 5(2):50–5.
- Shaw JG, Vaughan A, Dent AG, O’Hare PE, Goh F, Bowman RV, et al. Biomarkers of progression of Chronic Obstructive Pulmonary Disease (COPD). J Thorac Dis. 2014 Nov; 6(11):1532–47. DOI: 10.3978/ j.issn.2072-1439.2014.11.33.
- Eller J, Ede S, Schaberg T, Neiderman MS, Mauch H, Lode HO. Infective exacerbations of chronic bronchitis relation between bacteriological etiology and lung function.Chest. 1998; 113(6):1542–8. https://doi.org/10.1378/ chest.113.6.1542 PMid:9631791
- Saxena S, Ramnani VK, Nema S, Tripathi K, Dave L, Srivastava N. Bacteriological profile in acute exacerbation of Chronic Obstructive Lung Disease (AECOPD). Ann Int Med Den Res. 2016; 2(5):MB01– MB06. https://doi.org/10.21276/aimdr.2016.2.5.MB1
- Narayanagowda DS, Golia S, Jaiswal J, Manasa SS. A bacteriological study of acute exacerbation of chronic obstructive pulmonary disease over a period of one year. Int J Res Med Sci. 2015; 3:3141–6. https://doi.org/10.18203/2320-6012.ijrms20151152
- El Korashy RIM, El-Sherif RH. Gram negative organisms as a cause of acute exacerbation of COPD. Egyptian Journal of Chest Diseases and Tuberculosis. 2014; 63:345–9. https:// doi.org/10.1016/j.ejcdt.2013.12.013
- Study of Some Risk Factors in Acute Exacerbation of COPD at Tertiary Care Centre
Abstract Views :201 |
PDF Views:86
Authors
Juhi R. Kadukar
1,
Ramesh Sundrani
2,
Sushma Dugad
3,
Gauri Suhas Kulkarni
4,
Jaspreet Singh Khandpur
5,
Maya Mortale
1
Affiliations
1 Former PG Resident, Department of Respiratory Medicine, Dr. Vasantrao Pawar Medical College, Nashik - 422203, Maharashtra, IN
2 Professor and Head, Department of Respiratory Medicine, Dr. Vasantrao Pawar Medical College, Nashik - 422203, Maharashtra, IN
3 Associate Professor, Department of Respiratory Medicine, Dr. Vasantrao Pawar Medical College, Nashik - 422203, Maharashtra, IN
4 Professor, Department of Respiratory Medicine, Dr. Vasantrao Pawar Medical College, Nashik - 422203, Maharashtra, IN
5 PG Resident, Department of Respiratory Medicine, Dr. Vasantrao Pawar Medical College, Nashik - 422203, Maharashtra, IN
1 Former PG Resident, Department of Respiratory Medicine, Dr. Vasantrao Pawar Medical College, Nashik - 422203, Maharashtra, IN
2 Professor and Head, Department of Respiratory Medicine, Dr. Vasantrao Pawar Medical College, Nashik - 422203, Maharashtra, IN
3 Associate Professor, Department of Respiratory Medicine, Dr. Vasantrao Pawar Medical College, Nashik - 422203, Maharashtra, IN
4 Professor, Department of Respiratory Medicine, Dr. Vasantrao Pawar Medical College, Nashik - 422203, Maharashtra, IN
5 PG Resident, Department of Respiratory Medicine, Dr. Vasantrao Pawar Medical College, Nashik - 422203, Maharashtra, IN
Source
MVP Journal of Medical Sciences, Vol 7, No 1 (2020), Pagination: 98-103Abstract
Background: Respiratory symptoms of patients usually worsen, which may be beyond normal day to day variation this is nothing but an acute event of a disease leading to further change in medication. Acute exacerbation of Chronic obstructive pulmonary disease is defined as sudden worsening of symptoms like in breathlessness, chest pain, change in quantity and colour of sputum, fever, these symptoms usually last for several days. These symptoms are aggravated by environmental pollutants, bacterial and viral infections wherein infections usually lead to 75% or more of the exacerbations but improper inhaler technique is also one of the most important factors for causing exacerbation of Chronic Obstructive Pulmonary disease. Aims and Objectives: To study the risk factors for exacerbation of COPDs. Methods: Present sample consists of 51 diagnosed COPD patients who fulfilled eligibility criteria. Study was conducted in the department of Respiratory medicine from August 2016 to December2018. Detailed history along with general and respiratory system examination was done and findings were recorded. Results: Most of the study population was present between 51 to 60 years (41.2%) of age group and rest were in 41 to 50 years (29.4%) and more than 60 years (29.4%). There was male predominance (64.7%) amongst study population as compared to females (35.3%). 82.4% of study population were taking inhaler improperly. 64.7 % of study population were exposed to outdoor pollution. 43.1% of study population are exposed to indoor pollution. Conclusion: Environmental stress are also involved in acute exacerbation of chronic obstructive pulmonary disease apart from viral and bacterial infections. Improper technique of using inhaler was also the main risk. So patients are advised proper & regular use of inhaler technique. Indoor and outdoor pollution is also main risk factor for exacerbation so avoidance of exposure to biomass fuel and outdoor pollution should be considered.Keywords
Biomass Fuel, COPD, Improper Inhaler Technique, Indoor and Outdoor PollutionReferences
- Stockley RA. Neutrophils and the pathogenesis of COPD. Chest. 2002 May 1;121(5):151S-5S. https://doi.org/10.1378/ chest.121.5_suppl.151S. PMid:12010844.
- Lopez AD, Murray CC. The global burden of disease, 1990-2020. Nat Med. 1998; 4:1241-3. https://doi.
- org/10.1038/3218. PMid:9809543.
- Seemungal TA, Donaldson GC, Paul EA, Bestall JC, Jeffries DJ, Wedzicha JA. Effect of exacerbation on quality of life in patients with chronic obstructive pulmonary disease. American journal of respiratory and critical care medicine. 1998 May 1;157(5):1418-22. https://doi.org/10.1164/ajrccm.157.5.9709032. PMid:9603117.
- Pauwels R, Calverley P, Buist AS, Rennard S, Fukuchi Y, Stahl E, Löfdahl CG. COPD exacerbations: the importance of a standard definition. Respiratory medicine. 2004 Feb 1;98(2):99-107. https://doi.org/10.1016/j.rmed.2003.09.001. PMid:14971871.
- Connors Jr AF, Dawson NV, Thomas C, Harrell Jr FE, Desbiens N, Fulkerson WJ, Kussin P, Bellamy P, Goldman L, Knaus WA. Outcomes following acute exacerbation of severe chronic obstructive lung disease. The SUPPORT investigators (Study to Understand Prognoses and Preferences for Outcomes and Risks of Treatments). American journal of respiratory and critical care medicine. 1996 Oct;154(4):959-67. https://doi.org/10.1164/ajrccm.154.4.8887592. PMid:8887592.
- Ball P. Epidemiology and treatment of chronic bronchitis and its exacerbations. Chest. 1995 Aug 1;108(2):43S-52S.
- Sunyer J, Saez M, Murillo C, Castellsague J, Martinez F, Antó JM. Air pollution and emergency room admissions for chronic obstructive pulmonary disease: a 5-year study. American journal of epidemiology. 1993 Apr 1;137(7):7015.
- Carilli AD, Gohd RS, Gordon W. A virologic study of chronic bronchitis. N Engl J Med. 1964; 270:123-7. https://doi.org/10.1056/NEJM196401162700303. PMid:14067009.
- Monto AS, Bryan ER. Susceptibility to rhinovirus infection in chronic bronchitis. Am Rev Respir Dis. 1978; 118:11013.
- Smith CB, Golden CA, Kanner RE, Renzetti AD Jr. Association of viral and Mycoplasma pneumoniae infections with acute respiratory illness in patients with chronic obstructive pulmonary diseases. Am Rev Respir Dis. 1980; 121:225-32.
- Greenberg SB, Allen M, Wilson J, Atmar RL. Respiratory viral infections in adults with and without chronic obstructive pulmonary disease. American journal of respiratory and critical care medicine. 2000 Jul 1;162(1):167-73. https://doi.org/10.1164/ajrccm.162.1.9911019. PMid:10903237.
- Wedzicha JA, Donaldson GC. Exacerbations of chronic obstructive pulmonary disease. Respiratory care. 2003 Dec 1;48(12):1204-15. https://doi.org/10.1201/9780203913406.ch9.
- Stenhouse AC. Viral antibody levels and clinical status in acute exacerbations of chronic bronchitis: a controlled prospective study. Br Med J. 1968 Aug 3;3(5613):287-90. https://doi.org/10.1136/bmj.3.5613.287. PMid:4299087 PMCid:PMC1986246.
- Seemungal TA, Harper‐Owen R, Bhowmik A, Jeffries DJ, Wedzicha JA. Detection of rhinovirus in induced sputum at exacerbation of chronic obstructive pulmonary disease. European Respiratory Journal. 2000 Oct;16(4):67783. https://doi.org/10.1034/j.1399-3003.2000.16d19.x. PMid:11106212 PMCid:PMC7163563.
- Hasan A, Ashraf MU, Naaz S, Bhargava R, Ashraf J. A study of clinical and echocardiographic profile of patients of chronic obstructive pulmonary disease helping in early diagnosis of Corpulmonale. International Journal of Enhanced Research in Medicines and Dental care, ISSN. 2014:2349-1590.
- Guleria JS, Pande JN, Gupta RG. Chronic obstructive lung disease in Northern India. American Review of Respiratory Disease. 1969 Oct;100(4):490-8.
- Dirkje PS, Huib KAM. Epidemiology and natural history of chronic obstructive pulmonary disease. John GG, Duncan GM, Ulrich C, Peter SJ, Bryan C, editors. Respiratory Medicine. 3rd ed. Saunders; 2003. p. 1109-1120.
- Rachaiah NM, Rachaiah JM, Bhadravathi RK. A correlative study of spirometric parameters and ECG changes in patients with chronic obstructive pulmonary disease. Int J Biol Med Res. 2012; 3(1):1322-6.
- Narayanagowda DS, Golia S, Jaiswal J, Manasa SS. A bacteriological study of acute exacerbation of chronic obstructive pulmonary disease over a period of one year. Int J Res Med Sci 2015; 3:3141-6. https://doi.org/10.18203/23206012.ijrms20151152.
- Ganguly A, Das AK, Roy A. Study of proper use of inhalation devices by bronchial asthma or COPD patients attending a tertiary care hospital. J Clin Diagn Res. 2014; 8(10):HC047. https://doi.org/10.7860/JCDR/2014/9457.4976. PMid:25478367 PMCid:PMC4253185.
- Molimard M, Rahersion C, Lignot S. Chronic obstructive pulmonary disease exacerbation and inhaler device handling: Real-life assessment of 2935 patients. Eur Respir J. 2017; 49(2). https://doi.org/10.1183/13993003.017942016. PMid:28182569.